OrthoPediatrics Corp.

NASDAQ: KIDS · Real-Time Price · USD
19.30
0.17 (0.89%)
At close: Aug 15, 2025, 12:36 PM

OrthoPediatrics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
61.08M 52.41M 52.67M 54.57M 52.8M 44.69M 37.61M 39.97M 39.56M 31.59M 30.99M 34.95M 32.93M 23.42M 24.81M 25.08M 26.7M 21.46M
Cost of Revenue
17.06M 14.15M 17.1M 14.51M 16.78M 17.54M 16.38M 9.02M 9.53M 8.03M 9.77M 9.06M 7.95M 4.85M 6.73M 6.53M 6.25M 5.14M
Gross Profit
44.02M 38.26M 35.56M 40.06M 36.02M 27.15M 21.23M 30.95M 30.02M 23.56M 21.22M 25.89M 24.98M 18.57M 18.08M 18.55M 20.44M 16.32M
Operating Income
-7.69M -10.98M -8.57M -5.57M -5.67M -9.72M -8.07M -4.51M -5.59M -8.59M -8.31M -3.35M -3.74M -6.39M -5.56M -3.64M -2.85M -5.97M
Interest Income
n/a n/a n/a n/a n/a n/a 303K n/a n/a 210K 61K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-7.06M -10.46M -16.41M -9.14M -6.05M -10.34M -6.9M -3.74M -3.29M -7.38M -7.9M 14.4M -772K -9.42M -166K -2.49M -4.04M -10.69M
Net Income
-7.11M -10.66M -16.07M -7.92M -6.03M -7.8M -6.69M -4.59M -2.89M -6.81M -7.85M 18.54M -333K -9.1M 72K -2.2M -3.76M -10.38M
Selling & General & Admin
49.55M 46.85M 41.22M 43.05M 43.92M 38.9M 32.03M 32.09M 32.82M 29.88M 27.5M 27.04M 26.98M 22.93M 22.03M 20.9M 21.96M 20.99M
Research & Development
2.16M 2.35M 2.92M 2.58M 2.54M 3M 2.75M 2.39M 2.79M 2.27M 2.03M 2.21M 1.75M 2.03M 1.61M 1.3M 1.32M 1.31M
Other Expenses
n/a n/a 5.49M n/a -120K 24K 854K n/a 289K n/a -129K n/a n/a 105K n/a n/a n/a 160K
Operating Expenses
51.7M 49.2M 49.62M 45.63M 41.69M 36.87M 29.3M 34.48M 35.61M 32.15M 29.53M 29.24M 28.72M 24.95M 23.64M 22.2M 23.29M 22.3M
Interest Expense
1.12M 1.13M 1.32M 404K 261K 637K n/a 21K 294K 566K n/a 708K 1.21M 566K 396K 542K 581K 728K
Selling & Marketing Expenses
19.1M 16.57M 16.78M 16.75M 16.59M 14.17M 12.44M 13.58M 13.16M 12.22M 10.95M 11.92M 12.43M 9.76M 9.99M 9.86M 10.88M 8.95M
Cost & Expenses
68.77M 63.35M 66.72M 60.14M 58.47M 54.41M 45.68M 43.49M 45.15M 40.18M 39.3M 38.3M 36.67M 29.8M 30.37M 28.72M 29.54M 27.43M
Income Tax Expense
49K 196K -340K -1.22M -18K -2.53M -212K 849K -401K -574K -48K -4.14M -439K -317K -238K -292K -286K -312K
Shares Outstanding (Basic)
23.35M 23.23M 23.17M 23.17M 23.15M 22.82M 22.76M 22.76M 22.7M 22.51M 22.47M 21.15M 19.79M 19.37M 19.3M 19.29M 19.28M 19.2M
Shares Outstanding (Diluted)
23.35M 23.23M 23.17M 23.17M 23.15M 22.82M 22.76M 22.76M 22.7M 22.51M 22.47M 21.3M 19.79M 19.37M 19.3M 19.29M 19.28M 19.2M
EPS (Basic)
-0.3 -0.46 -0.69 -0.34 -0.26 -0.34 -0.29 -0.2 -0.13 -0.3 -0.35 0.88 -0.02 -0.47 0.00 -0.11 -0.19 -0.54
EPS (Diluted)
-0.3 -0.46 -0.69 -0.34 -0.26 -0.34 -0.29 -0.2 -0.13 -0.3 -0.35 0.87 -0.02 -0.47 0.00 -0.11 -0.19 -0.54
EBITDA
-7.69M -4.29M -1.31M -3.45M -1.01M -4.7M -6.28M 549K 1.09M -4.74M -4.05M 18.39M 3.77M -3.42M 3.04M 776K -853K -7.42M
EBIT
n/a -9.34M -5.3M -8.73M -5.79M -9.72M -6.9M -3.72M -2.99M -8.59M -7.96M 15.1M 440K -6.39M 230K -1.95M -3.46M -9.96M
Depreciation & Amortization
n/a 5.05M 3.99M 5.28M 4.78M 5.03M 5.48M 4.27M 4.08M 3.85M 3.84M 3.29M 3.33M 2.96M 2.81M 2.72M 2.61M 2.54M